Thomas E. Duley is of counsel in Morgan Lewis’s Business and Finance Practice. Mr. Duley has more than 10 years of experience in life sciences transactions and intellectual property litigation matters. He has negotiated, drafted, and managed a variety of intellectual property transactions for life sciences companies, including collaboration agreements between biotechnology and pharmaceutical companies, licensing agreements with commercial businesses and academic institutions, supply and manufacturing agreements, and asset purchases and sales involving drug products and manufacturing facilities. He has overseen real estate and construction contracts, and guided and implemented formal contracting policies in compliance with Sarbanes-Oxley regulations. Mr. Duley is also a licensed architect, with experience in designing laboratories.
Prior to joining Morgan Lewis, Mr. Duley was senior corporate counsel and head of the transactional legal group at PDL BioPharma, Inc., a publicly traded biopharmaceutical company that researches, develops, manufactures, and sells pharmaceutical products. In that capacity, he was responsible for all general commercial and intellectual property contracts on behalf of PDL, including managing legal issues arising from collaborations with pharmaceutical and biotechnology companies.
Mr. Duley received his J.D. from the University of California, Davis School of Law in 1995, where he was senior articles editor for the U.C. Davis Law Review. He received his Master of Architecture degree in 1987 and his B.A. in English literature in 1983 from the University of California, Los Angeles.
Mr. Duley is admitted to practice in California.more » « less